Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000038703 | SCV000062381 | likely benign | not specified | 2014-12-30 | criteria provided, single submitter | clinical testing | c.480+3A>G in intron 5 of NEBL: This variant is not expected to have clinical si gnificance because it has been identified in 0.4% (303/67668) of European chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs71578983). |
Gene |
RCV000229652 | SCV000236091 | benign | not provided | 2020-05-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001079614 | SCV000289533 | benign | Primary dilated cardiomyopathy | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000621845 | SCV000739783 | uncertain significance | Cardiovascular phenotype | 2013-05-27 | criteria provided, single submitter | clinical testing | There is insufficient or conflicting evidence for classification of this alteration. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000038703 | SCV004803597 | benign | not specified | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000229652 | SCV001928642 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000229652 | SCV001968836 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003944921 | SCV004774028 | likely benign | NEBL-related disorder | 2019-07-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |